Curasight: Brain cancer first indication for uTREAT

Research Note

2024-11-12

08:54

Redeye gives a short comment on yesterday’s news that Curasight has announced brain cancer as the first indication for uTREAT.

Fredrik Thor

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.